hhs_forecastForecaste2hq81d8rlj
RSAR: Post-marketing RX Drug Abuse Surveillance Data - IBH Data Source
Department of Health and Human Services.Food and Drug Administration.75F401.75F402
- Est. solicitation
- Nov 1, 2026
- Date posted
- —
- Source
- Open forecast
Description
The primary objective of this effort is for the FDA to obtain post-marketing data on NMU of prescription and over-the-counter drugs and use of illegal substances from individuals entering treatment centers or being assessed for treatment of substance use disorders.
Planning details
- Estimated value
- >= $250K and < $700K
- Est. solicitation date
- Nov 1, 2026
- Anticipated award
- Mar 1, 2027
Classifications
- NAICS541990
- PSC541990